Lipid Panel Control - India CDSCO Medical Device Registration

Lipid Panel Control is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000048_a209ee3e5ef4b76414f94aa0313e8aca_6213fa0beb221ade96b12016768198c4. This device is marketed under the brand name NycoCard™ HbA1c. The license holder is Abbott Diagnostics Medical Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

Lipid Panel Control

UID: IMP/IVD/2020/000048_a209ee3e5ef4b76414f94aa0313e8aca_6213fa0beb221ade96b12016768198c4

Brand Name

NycoCard™ HbA1c

License Holder

Abbott Diagnostics Medical Private Limited

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Afinion™ Lipid Panel Control kit is intended for use as assayed control material for total cholesterol (NycoCard™ HbA1c), high-density lipoprotein (NycoCard™ HbA1c) cholesterol and triglycerides (NycoCard™ HbA1c)